Entering the US market II: US market insights

As part of the Health3-2-1 project, we invite you to our second US market event, where we will explore what it actually takes to do business in America.

Date: 31.10.2024
Time: 15:00-16:00 CET/Sweden  - 16:00-17:00 EET /Finland and Estonia
Location: Teams

Whether you’re a business leader, entrepreneur, or SME looking to expand into the US, this session is designed to offer valuable insights tailored to the life sciences sectors (HealthTech, MedTech, BioTech, and Pharma).

15:00/16:00 Opening words
Welcoming remarks and introduction to the seminar. Short overview of Health3-2-1 project, by Tero Piispanen, Business Turku Ltd.

15:10/16:10 The business steps needed to enter the US market
An analysis of what it takes to actually conduct and operate business in the USA.
Speaker:  John Pennett , Partner, Life Sciences and, Technology Group, Eisner Advisory Group LLC

EisnerAmper LLP and Eisner Advisory Group LLC are member firms of EisnerAmper Global Ltd., a network of legally independent firms, and of Allinial Global, an association of legally independent accounting and consulting firms. John Pennett is also a member of Mid-Atlantic Bioangels, a life-sciences angel network.

15:30/16:30 Finding the right people to build your business in the U.S. - key facts based on experience
Experiences of pitfalls and best practices conducted by companies entering the US.
Speaker:  Kimmo Kartano, Frontrunner Executive Search LLC

Kimmo Kartano has lived in the United States for about 30 years. He is the founder of Frontrunner Executive Search LLC, which has been operating in the United States for more than 10 years. Kimmo is also the U.S. partner of Glasford International, a global executive search with 150 consultants in 20 countries. Kimmo has conducted executive searches for technology clients and served many European companies from Finland, Sweden, Germany and other countries in medtech and other fields. He recruits for roles in general management and sales/commercial positions as well as for demanding product development and technical positions.

15:50/16:50 Open discussion and final remarks
Opportunity for participants to ask additional questions or discuss topics further

16:00/17:00 End of program


The session will be recorded, and all registered participants will receive a copy after the event.
 

Health3-2-1 is an EU Interreg-funded project led by Tehnopol Science and Business Park (EE), Business Turku (FI), and Swecare (SE). The project aims to support small and medium-sized enterprises in the life sciences sector as they expand into export markets in the UK (London) and the US (Massachusetts or the Washington Metropolitan Area).

Selected companies will receive a comprehensive support package valued at up to €20,000, including tailored mentoring, thematic seminars, and up to two business missions to the target markets.

A limited number of companies will be selected to participate and receive support in reaching active sales.
 

If you have questions about the webinars, don't hesitate to email us:
Ulf Borbos: ulf.borbos@swecare.se
Anna Riby: anna.riby@swecare.se
Tero Piisplanen: ero.piispanen@businessturku.fi